VBL Therapeutics
Targeted Therapies for Immune-inflammatory Diseases
Active
Public
Startup
Acquired
Modi'in-Maccabim-Re'ut
Founded 2000-01
VBL has developed its Monocyte Targeting Technology (MTT), as an investigational new and specific way to limit chronic inflammation. Its program is based on the discovery of a novel target protein that is selectively expressed on the surface of monocytes and controls their ability to migrate (or 'walk' to) inflamed tissues. This protein is called MOSPD2 (th…
SectorHealth Tech & Life Sciences
StagePublic
Total raised$109.8M
Employees14
Founded2000-01
HQModi'in-Maccabim-Re'ut
Crunchbasevbl-therapeutics
Patents1
Confidence100
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals